Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

Bullboard Posts

Post by Danweskeron Jun 13, 2019 5:07pm

197 Views

Post# 29824157

Quick newbie question

Hey guys,

Just a quick quesiton on the bought deal financing that just recently happened. Is anyone familar with when things like this happen and why the stock price would drop?

Labs had a profitable 2018, and first quarter 2019 with record revenues of 22 million, and a bought deal priced at $5.55 per share. Assuming the people who did the bought deal know what they are doing I'm assuming $5.55 would be the fair price, but why is it currently trading lower than that?

Is this a pattern that always happens when bought deals happen where it goes below the bought deal price, but then later recovers?

Please feel free to share thoughts, thanks!

Dan

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment